logo

FATE

Fate Therapeutics·NASDAQ
--
--(--)
--
--(--)
3.95 / 10
Netural

The fund flow profile scores 7.9/10, demonstrating robust fund flow characteristics. Favorable overall, block, Small, and Extra-large movements are tempered by challenging Medium and Large dynamics, supporting positive flow assessment. Analyst perspective reveals predominantly positive analyst sentiment with moderate confidence. Rating breakdown: Strong Buy(33.3%), Buy(33.3%), Neutral(33.3%) from 3 analyst assessments, supported by 0.00 historical weighted rating.

FundamentalSentiment(3.95)Technical
Fund Flow Rating
Analyst RatingStrong Buy

Wall Street Opinions

Strong Buy

Strong Buy

33%

Buy

33%

Hold

0%

Sell

0%

Strong Sell

0%

Date2025-10-27
InstitutionWedbush
Times predicted2
Historical Win Rate0.0%
What is the analyst consensus for FATE?
  • FATE holds a Bearish analyst rating, with 33% of experts assigning a Strong Buy grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 3.95/10 (Netural).